Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna...
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Moderna (NASDAQ:MRNA) through any online brokerage.
Other companies in Moderna’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Moderna has a consensus price target of $71.71.
The stock price for Moderna (NASDAQ: MRNA) is $191.23 last updated September 30, 2026 at 7:59 PM EDT.
There are no upcoming dividends for Moderna.
Moderna does not have any upcoming earnings scheduled.
There is no upcoming split for Moderna.
Moderna is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
